|
Persistent Identifier
|
perma:LIST.1PD7WG |
|
Publication Date
|
2026-07-06 |
|
Title
| A metabolic constraint in de novo NAD+ synthesis drives mucosal inflammation in IBD [* Cross-Reference *] |
|
Other Identifier
| https://doi.org/10.1093/ecco-jcc/jjag043
OpenAlex ID: https://openalex.org/W7162998786 |
|
Author
| Lina Wehkamp (Christian-Albrechts-Universität zu Kiel)
D Harris (Christian-Albrechts-Universität zu Kiel)
Na‐Mi Kim (Christian-Albrechts-Universität zu Kiel)Christian-Albrechts-Universität zu KielORCIDhttps://orcid.org/0000-0002-3518-3818
Abrar I. Alsaadi (Pennsylvania State University)
Qicong Wu (Christian-Albrechts-Universität zu Kiel)
Mhmd Oumari (Christian-Albrechts-Universität zu Kiel)Christian-Albrechts-Universität zu KielORCIDhttps://orcid.org/0009-0008-4977-7888
Jan Taubenheim (Christian-Albrechts-Universität zu Kiel)Christian-Albrechts-Universität zu KielORCIDhttps://orcid.org/0000-0001-7283-1768
Valery Volk (Medizinische Hochschule Hannover)Medizinische Hochschule HannoverORCIDhttps://orcid.org/0000-0002-8928-4470
G Credidio (Christian-Albrechts-Universität zu Kiel)
Eric Koncina (University of Luxembourg, Luxembourg Institute of Science and Technology)University of Luxembourg, Luxembourg Institute of Science and TechnologyORCIDhttps://orcid.org/0000-0003-4764-1510
Pranab K. Mukherjee (King's College London, Cleveland Clinic Lerner College of Medicine)King's College London, Cleveland Clinic Lerner College of MedicineORCIDhttps://orcid.org/0000-0003-0244-6068
Florian Tran (Christian-Albrechts-Universität zu Kiel)Christian-Albrechts-Universität zu KielORCIDhttps://orcid.org/0000-0002-3735-9872
Taous Mekdoud (Christian-Albrechts-Universität zu Kiel)
Meiping Yu (Christian-Albrechts-Universität zu Kiel)Christian-Albrechts-Universität zu KielORCIDhttps://orcid.org/0000-0002-0351-6964
Laura Katharina Sievers (Christian-Albrechts-Universität zu Kiel)Christian-Albrechts-Universität zu KielORCIDhttps://orcid.org/0000-0002-4677-5181
Polychronis Pavlidis (Cleveland Clinic, King's College London)Cleveland Clinic, King's College LondonORCIDhttps://orcid.org/0000-0003-4864-2208
Nick Powell (Imperial College London)Imperial College LondonORCIDhttps://orcid.org/0000-0003-3231-6950
Shihan Wang (Christian-Albrechts-Universität zu Kiel)Christian-Albrechts-Universität zu KielORCIDhttps://orcid.org/0000-0002-0045-9036
Ivan Fung (Amsterdam University Medical Centers)Amsterdam University Medical CentersORCIDhttps://orcid.org/0009-0008-5333-0915
Georg H. Waetzig (Hochschule für Angewandte Wissenschaften Kiel, Christian-Albrechts-Universität zu Kiel)Hochschule für Angewandte Wissenschaften Kiel, Christian-Albrechts-Universität zu KielORCIDhttps://orcid.org/0000-0001-8289-2097
Christel Rousseaux (Active Biotech (Sweden))Active Biotech (Sweden)ORCIDhttps://orcid.org/0009-0003-3618-5895
Pierre Desreumaux (Active Biotech (Sweden))Active Biotech (Sweden)ORCIDhttps://orcid.org/0000-0002-6127-5281
Florian Rieder (Cleveland Clinic, King's College London, Cleveland Clinic Lerner College of Medicine)Cleveland Clinic, King's College London, Cleveland Clinic Lerner College of MedicineORCIDhttps://orcid.org/0000-0002-9087-1568
Elisabeth Letellier (University of Luxembourg, Luxembourg Institute of Science and Technology)University of Luxembourg, Luxembourg Institute of Science and TechnologyORCIDhttps://orcid.org/0000-0001-8242-9393
Silvio Waschina (Hochschule für Angewandte Wissenschaften Kiel)Hochschule für Angewandte Wissenschaften KielORCIDhttps://orcid.org/0000-0002-6290-3593
Thomas F Meyer (Christian-Albrechts-Universität zu Kiel, Max Planck Institute for Infection Biology)
Timon Adolph (Innsbruck Medical University)
Geert D’Haens (Amsterdam University Medical Centers)Amsterdam University Medical CentersORCIDhttps://orcid.org/0000-0003-2784-4046
Christoph Kaleta (Christian-Albrechts-Universität zu Kiel)
Friedrich Feuerhake (Medizinische Hochschule Hannover)Medizinische Hochschule HannoverORCIDhttps://orcid.org/0000-0002-1234-982X
Bram Verstockt (KU Leuven)KU LeuvenORCIDhttps://orcid.org/0000-0003-3898-7093
Melanie R. McReynolds (Pennsylvania State University)Pennsylvania State UniversityORCIDhttps://orcid.org/0000-0001-5427-2739
Philip Rosenstiel (Christian-Albrechts-Universität zu Kiel)
Stefan Schreiber (Christian-Albrechts-Universität zu Kiel)Christian-Albrechts-Universität zu KielORCIDhttps://orcid.org/0000-0003-2254-7771
Konrad Aden (Christian-Albrechts-Universität zu Kiel)Christian-Albrechts-Universität zu KielORCIDhttps://orcid.org/0000-0003-3482-7316 |
|
Point of Contact
|
Use email button above to contact.
LIST QDKM (LIST) |
|
Description
| Background: Inflammatory bowel disease (IBD) is associated with energy deficiency and perturbed metabolism of the essential amino acid tryptophan (Trp). Objective: We aimed to determine whether excessive Trp degradation fuels or compensates for inflammation through de novo nicotinamide adenine dinucleotide (NAD+) synthesis. Design: A prospective systems medicine approach (metabolomics, transcriptomics) was employed longitudinally in patients with advanced IBD therapy. Findings were validated with targeted Trp metabolomics in experimental colitis and in vitro in fibroblasts, intestinal epithelial cells (IECs), and peripheral blood mononuclear cells (PBMCs). Results: Active IBD is marked by enhanced Trp degradation driven by inflammatory cytokines through the JAK/STAT pathway. Trp catabolism results in accumulation of quinolinic acid (QA) and NAD + depletion due to reduced expression of QPRT, the enzyme converting QA to NAD+. QPRT knockdown enhances inflammation, while NAD + precursor supplementation (e.g. nicotinamide riboside [NR]) restores cellular energy and reduces inflammation in vitro and in dextran sodium sulfate (DSS)-induced colitis. Conclusion: A metabolic bottleneck at QPRT prevents efficient NAD+ synthesis from Trp in IBD, sustaining inflammation. Restoring NAD + is a promising therapeutic strategy. (2026-03-18)
***This entry has been automatically imported via OpenAlex by LIST harvest scripts. Please refer to https://doi.org/10.1093/ecco-jcc/jjag043 for the original and latest version of the publication*** (2026-07-01) |
|
Subject
| Chemistry; Medicine, Health and Life Sciences |
|
Keyword
| NAD+ kinase
Inflammatory bowel disease
Inflammation
Quinolinic acid
Catabolism
Nicotinamide adenine dinucleotide
Peripheral blood mononuclear cell
Colitis
Nicotinamide phosphoribosyltransferase
Nicotinamide |
|
Topic Classification
| Sirtuins and Resveratrol in Medicine
Calcium signaling and nucleotide metabolism
Tryptophan and brain disorders |
|
Deposit Date
| 2026-03-18 |
|
Data Type
| Article |
|
Data Source
| Journal of Crohn s and Colitis |